Uploaded January 2022 | Updated September 2026, 4 days ago
Chimeric antigen receptor (CAR) T cell therapy is an immunotherapy. It uses a patient’s own immune system to fight certain blood cancers.
Huntsman Cancer Institute is one of only a handful of hospitals in the United States authorized to offer the two CAR T cell therapies currently approved by the U.S. Food and Drug Administration.
To learn more about CAR T cell therapy, call our referral center at 801-587-4652 or visit huntsmancancer.org/car-t
Chimeric antigen receptor (CAR) T cell therapy is an immunotherapy. It uses a patient’s own immune system to fight certain blood cancers.
Huntsman Cancer Institute is one of only a handful of hospitals in the United States authorized to offer the two CAR T cell therapies currently approved by the U.S. Food and Drug Administration.
To learn more about CAR T cell therapy, call our referral center at 801-587-4652 or visit huntsmancancer.org/car-t
